ChestEze

From Wikipedia, the free encyclopedia

This article is orphaned as few or no other articles link to it.
Please help introduce links in articles on related topics. (June 2008)

This article may not meet the general notability guideline or one of the following specific guidelines for inclusion on Wikipedia: Biographies, Books, Companies, Fiction, Music, Neologisms, Numbers, Web content, or several proposals for new guidelines. If you are familiar with the subject matter, please expand or rewrite the article to establish its notability. The best way to address this concern is to reference published, third-party sources about the subject. If notability cannot be established, the article is more likely to be considered for redirection, merge or ultimately deletion, per Wikipedia:Guide to deletion.
This article has been tagged since June 2008.

This article does not cite any references or sources. (June 2008)
Please help improve this article by adding citations to reliable sources. Unverifiable material may be challenged and removed.

ChestEze is a British over-the-counter pharmaceutical product manufactured by Do-Do for "relief of bronchial cough, wheezing, breathlessness and other symptoms of asthmatic bronchitis and to clear the chest of mucus following upper respiratory tract infection." It contains 30mg caffeine, 18.31mg ephedrine hydrochloride and 100mg anhydrous theophylline.

It comes in a fawn brown tablet. Recommended doses are: Adults: not more than 1 tablet in 4 hours. Maximum 4 tablets in 24 hours. Young persons over 12 years: 1 tablet and no more than 3 tablets daily with an interval of at least 4 hours between each tablet.

Because ChestEze contains ephedrine, which is illegal in its pure form in the UK, it is sometimes used illicitly in large doses by bodybuilders. This use can be dangerous, however, since theophylline can be toxic at relatively low doses.